Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARα and PPARγ agonists
Author:
Publisher
Hindawi Limited
Subject
General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1368-504X.2004.00376.x/fullpdf
Reference71 articles.
1. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management;Beckman;JAMA,2002
2. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance;Haffner;Am J Cardiol,2002
3. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis;Barbier;Arterioscler Thromb Vasc Biol,2002
4. The mechanisms of action of PPARs;Berger;Ann Rev Med,2002
5. Regulation of lipid and lipoprotein metabolism by PPAR activators;Gervois;Clin Chem Laboratory Med,2000
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of resveratrol in inhibiting pathological cardiac remodeling;Frontiers in Pharmacology;2022-09-01
2. 4,5-diazafenylfluorene-rhodanine conjugates promote anoikis in A375 cells via inhibiting PPAR-γ expression;Medicinal Chemistry Research;2022-07-13
3. Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review;Current Molecular Medicine;2021-12-06
4. Hyperkeratinization and Proinflammatory Cytokine Expression in Meibomian Glands Induced by Staphylococcus aureus;Investigative Opthalmology & Visual Science;2021-10-13
5. Hyperlipidemia induces meibomian gland dysfunction;The Ocular Surface;2019-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3